Skip to main content

Oxidative Stress in Kawasaki Disease

  • Chapter
  • First Online:
Kawasaki Disease
  • 1286 Accesses

Abstract

Because inflammation and oxidative stress are closely related, oxidative stress cannot be ignored when considering pathologic conditions associated with inflammation-based Kawasaki disease (KD). KD pathogenesis is triggered by certain unknown infectious factors that activate one or multiple inflammation pathways via intricately intertwined cytokine cascades. Overproduction of reactive oxygen species from activated inflammation pathways increases oxidative stress in the body and results in an endless vicious cycle between inflammation reactions and reactive oxygen, which presumably underlies the diffuse vasculitis formed during acute KD. Although vascular inflammation and oxidative stress can be rapidly suppressed by treatment during the acute phase, they may persist in various forms for a long time. This has recently been identified as a concern in late KD. Generally, the presence of vascular inflammation and oxidative stress impairs blood vessels, leading to atherosclerosis onset, a widely recognized risk (Li et al., Atherosclerosis 237(1):208–219, 2014). This chapter will focus on determining whether the same is valid for blood vessels in late KD.

This is a preview of subscription content, log in via an institution to check access.

Access this chapter

Chapter
USD 29.95
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
eBook
USD 109.00
Price excludes VAT (USA)
  • Available as EPUB and PDF
  • Read on any device
  • Instant download
  • Own it forever
Softcover Book
USD 139.99
Price excludes VAT (USA)
  • Compact, lightweight edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info
Hardcover Book
USD 199.99
Price excludes VAT (USA)
  • Durable hardcover edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info

Tax calculation will be finalised at checkout

Purchases are for personal use only

Institutional subscriptions

References

  1. Sies H. What is oxidative stress? In: Kency Jr JF, editor. Oxidative stress and vascular disease. Boston: Kluwer Academic Publishers; 2000. p. 1–8. 10.1007/978-1-4615-4649-8_1.

    Chapter  Google Scholar 

  2. Takahashi K, Oharaseki T, Naoe S, Wakayama M, Yokouchi Y. Neutrophilic involvement in the damage to coronary arteries in acute stage of Kawasaki disease. Pediatr Int. 2005;47(3):305–10. http://dx.doi.org/10.1111/j.1442-200x.2005.02049.x. PMID:15910456.

    Article  PubMed  Google Scholar 

  3. Griendling KK, Sorescu D, Ushio-Fukai M. NAD(P)H oxidase: role in cardiovascular biology and disease. Circ Res. 2000;86(5):494–501. http://dx.doi.org/. 10.1161/01.RES.86.5.494. PMID:10720409.

    Article  CAS  PubMed  Google Scholar 

  4. Kumar U, Chen J, Sapoznikhov V, Canteros G, White BH, Sidhu A. Overexpression of inducible nitric oxide synthase in the kidney of the spontaneously hypertensive rat. Clin Exp Hypertens. 2005;27(1):17–31. http://dx.doi.org/10.1081/CEH-200044249. PMID:15773227.

    Article  CAS  PubMed  Google Scholar 

  5. Takatsuki S, Ito Y, Takeuchi D, Hoshida H, Nakayama T, Matsuura H, Saji T. IVIG reduced vascular oxidative stress in patients with Kawasaki disease. Circ J. 2009;73(7):1315–8. http://doi.org/10.1253/circj.CJ-07-0635. PMID:19436119.

  6. Yahata T, Suzuki C, Hamaoka A, Fujii M, Hamaoka K. Dynamics of reactive oxygen metabolites and biological antioxidant potential in the acute stage of Kawasaki disease. Circ J. 2011;75(10):2453–9. http://dx.doi.org/10.1253/circj.CJ-10-0605. PMID:21785226.

    Article  CAS  PubMed  Google Scholar 

  7. Shen CT, Wang NK. Antioxidants may mitigate the deterioration of coronary arteritis in patients with Kawasaki disease unresponsive to high-dose intravenous gamma-globulin. Pediatr Cardiol. 2001;22(5):419–22. http://dx.doi.org/10.1007/s002460010268. PMID:11526424.

    Article  CAS  PubMed  Google Scholar 

  8. Steer KA, Wallace TM, Bolton CH, Hartog M. Aspirin protects low density lipoprotein from oxidative modification. Heart. 1997;77(4):333–7. http://dx.doi.org/10.1136/hrt.77.4.333. PMID:9155612.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  9. Kobayashi T, Saji T, Otani T, Takeuchi K, Nakamura T, Arakawa H, RAISE study group investigators, et al. Efficacy of immunoglobulin plus prednisolone for prevention of coronary artery abnormalities in severe Kawasaki disease (RAISE study): a randomised, open-label, blinded-endpoints trial. Lancet. 2012;379(9826):1613–20. http://dx.doi.org/10.1016/S0140-6736(11)61930-2. PMID:22405251.

    Article  CAS  PubMed  Google Scholar 

  10. Suzuki H, Terai M, Hamada H, Honda T, Suenaga T, Takeuchi T, et al. Cyclosporin A treatment for Kawasaki disease refractory to initial and additional intravenous immunoglobulin. Pediatr Infect Dis J. 2011;30(10):871–6. http://dx.doi.org/10.1097/INF.0b013e318220c3cf. PMID:21587094.

    Article  PubMed  Google Scholar 

  11. Tremoulet AH, Jain S, Jaggi P, Jimenez-Fernandez S, Pancheri JM, Sun X, et al. Infliximab for intensification of primary therapy for Kawasaki disease: a phase 3 randomised, double-blind, placebo-controlled trial. Lancet. 2014;383(9930):1731–8. http://dx.doi.org/10.1016/S0140-6736(13)62298-9. PMID:24572997.

    Article  CAS  PubMed  Google Scholar 

  12. Niboshi A, Hamaoka K, Sakata K, Yamaguchi N. Endothelial dysfunction in adult patients with a history of Kawasaki disease. Eur J Pediatr. 2008;167(2):189–96. http://dx.doi.org/10.1007/s00431-007-0452-9. PMID:17345094.

    Article  CAS  PubMed  Google Scholar 

  13. Ross R. The pathogenesis of atherosclerosis: a perspective for the 1990s. Nature. 1993;362(6423):801–9. http://dx.doi.org/10.1038/362801a0. PMID:8479518.

    Article  CAS  PubMed  Google Scholar 

  14. Steinberg D, Parthasarathy S, Carew TE, Khoo JC, Witztum JL. Beyond cholesterol. Modifications of low-density lipoprotein that increase its atherogenicity. N Engl J Med. 1989;320(14):915–24. PMID:2648148.

    Article  CAS  PubMed  Google Scholar 

  15. Kawashima S, Yokoyama M. Dysfunction of endothelial nitric oxide synthase and atherosclerosis. Arterioscler Thromb Vasc Biol. 2004;24(6):998–1005. http://dx.doi.org/10.1161/01.ATV.0000125114.88079.96. PMID:15001455.

    Article  CAS  PubMed  Google Scholar 

  16. Guzik TJ, Mussa S, Gastaldi D, Sadowski J, Ratnatunga C, Pillai R, et al. Mechanisms of increased vascular superoxide production in human diabetes mellitus: role of NAD(P)H oxidase and endothelial nitric oxide synthase. Circulation. 2002;105(14):1656–62. http://dx.doi.org/10.1161/01.CIR.0000012748.58444.08. PMID:11940543.

    Article  CAS  PubMed  Google Scholar 

  17. Takahashi K, Oharaseki T, Naoe S. Pathological study of postcoronary arteritis in adolescents and young adults: with reference to the relationship between sequelae of Kawasaki disease and atherosclerosis. Pediatr Cardiol. 2001;22(2):138–42. http://dx.doi.org/10.1007/s002460010180. PMID:11178671.

    Article  CAS  PubMed  Google Scholar 

  18. Mitani Y, Ohashi H, Sawada H, Ikeyama Y, Hayakawa H, Takabayashi S, et al. In vivo plaque composition and morphology in coronary artery lesions in adolescents and young adults long after Kawasaki disease: a virtual histology-intravascular ultrasound study. Circulation. 2009;119(21):2829–36. http://dx.doi.org/10.1161/CIRCULATIONAHA.108.818609. PMID:19451352.

    Article  PubMed  Google Scholar 

  19. Liu Y, Onouchi Z, Sakata K, Ikuta K. An experimental study on the role of smooth muscle cells in the pathogenesis of atherosclerosis of the coronary arteritis. J Jpn Pediatr Soc. 1996;100:1453–8.

    Google Scholar 

  20. Hamaoka-Okamoto A, Suzuki C, Yahata T, Ikeda K, Nagi-Miura N, Ohno N, et al. The involvement of the vasa vasorum in the development of vasculitis in animal model of Kawasaki disease. Pediatr Rheumatol Online J. 2014;12(1):12. http://dx.doi.org/10.1186/1546-0096-12-12. PMID:24678599.

    Article  PubMed  PubMed Central  Google Scholar 

  21. Deng YB, Xiang HJ, Chang Q, Li CL. Evaluation by high-resolution ultrasonography of endothelial function in brachial artery after Kawasaki disease and the effects of intravenous administration of vitamin C. Circ J. 2002;66(10):908–12. http://dx.doi.org/10.1253/circj.66.908. PMID:12381083.

    Article  PubMed  Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to Tomoyo Yahata .

Editor information

Editors and Affiliations

Rights and permissions

Reprints and permissions

Copyright information

© 2017 Springer Japan

About this chapter

Cite this chapter

Yahata, T., Hamaoka, K. (2017). Oxidative Stress in Kawasaki Disease. In: Saji, B., Newburger, J., Burns, J., Takahashi, M. (eds) Kawasaki Disease. Springer, Tokyo. https://doi.org/10.1007/978-4-431-56039-5_38

Download citation

  • DOI: https://doi.org/10.1007/978-4-431-56039-5_38

  • Published:

  • Publisher Name: Springer, Tokyo

  • Print ISBN: 978-4-431-56037-1

  • Online ISBN: 978-4-431-56039-5

  • eBook Packages: MedicineMedicine (R0)

Publish with us

Policies and ethics